GRAY MARY ANN — SEC Form 4 filings
SEC reporting owner CIK 1261974. 14 Form 4 filings on record with FilingPulse; latest filed 2026-06-05.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-14 to 2026-06-05. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 29.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. (RAPT) | Director | 6 | — | — | 19 |
| Keros Therapeutics, Inc. (KROS) | Director | 3 | — | — | 5 |
| Compass Therapeutics, Inc. (CMPX) | Director | 3 | — | — | 3 |
| BioAtla, Inc. (BCAB) | Director | 2 | — | — | 2 |
Form 4 filings — GRAY MARY ANN
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-05 | 4 | Keros Therapeutics, Inc. (KROS) | Grant/award (A): 7,142 @ $0 · Grant/award (A): 7,433 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | RAPT Therapeutics, Inc. (RAPT) | Code (U): 4,956 · Disposition to issuer (D): 2,813 (derivative) · Disposition to issuer (D): 498 (derivative) · Disposition to issuer (D): 938 (derivative) · Disposition to issuer (D): 478 (derivative) · Disposition to issuer (D): 938 (derivative) · +8 more | EDGAR |
| 2026-02-02 | 4 | RAPT Therapeutics, Inc. (RAPT) | Grant/award (A): 4,956 @ $0 | EDGAR |
| 2026-01-05 | 4 | Compass Therapeutics, Inc. (CMPX) | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-06-18 | 4 | BioAtla, Inc. (BCAB) | Grant/award (A): 23,500 @ $0 | EDGAR |
| 2025-06-06 | 4 | Keros Therapeutics, Inc. (KROS) | Grant/award (A): 5,250 @ $0 · Grant/award (A): 10,500 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | RAPT Therapeutics, Inc. (RAPT) | Grant/award (A): 257,832 (derivative) @ $0 | EDGAR |
| 2025-04-02 | 4 | RAPT Therapeutics, Inc. (RAPT) | Grant/award (A): 61,202 (derivative) @ $1.06 | EDGAR |
| 2025-02-13 | 4 | Compass Therapeutics, Inc. (CMPX) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | BioAtla, Inc. (BCAB) | Grant/award (A): 16,500 @ $0 | EDGAR |
| 2024-06-03 | 4 | Keros Therapeutics, Inc. (KROS) | Grant/award (A): 10,000 (derivative) @ $0 | EDGAR |
| 2024-05-23 | 4 | RAPT Therapeutics, Inc. (RAPT) | Grant/award (A): 36,490 (derivative) @ $0 | EDGAR |
| 2024-04-01 | 4 | RAPT Therapeutics, Inc. (RAPT) | Grant/award (A): 8,574 (derivative) @ $7.58 | EDGAR |
| 2024-02-14 | 4 | Compass Therapeutics, Inc. (CMPX) | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1261974 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →